Claim: Indivior is a spinoff of Reckitt Benckiser and was capitalized at £2.3 billion (US$3.1 billion) on the London Stock Exchange in 2015.
Evidence: In December 2014, RB spun off its speciality pharmaceuticals business, which produces Suboxone (an opioid withdrawal medication), into a separate company named Indivior. By February 2015, the company was capitalised at £2.3 billion (US$3.1 billion) on the London Stock Exchange.